Multidrug resistance protein 1 (MRP1) is a transporter protein that helps to protect normal cells and tumor cells against the influx of certain xenobiotics. We previously showed that Mrp1 protects against cytotoxic drugs at the testis-blood barrier, the oral epithelium, and the kidney urinary collecting duct tubules. Here, we generated Mrp1/Mdr1a/Mdr1b triple-knockout (TKO) mice, and used them together with Mdr1a/Mdr1b double-knockout (DKO) mice to study the contribution of Mrp1 to the tissue distribution and pharmacokinetics of etoposide. We observed increased toxicity in the TKO mice, which accumulated etoposide in brown adipose tissue, colon, salivary gland, heart, and the female urogenital system. Immunohistochemical staining revealed the presence of Mrp1 in the oviduct, uterus, salivary gland, and choroid plexus (CP) epithelium. To explore the transport function of Mrp1 in the CP epithelium, we used TKO and DKO mice cannulated for cerebrospinal fluid (CSF). We show here that the lack of Mrp1 protein causes etoposide levels to increase about 10-fold in the CSF after intravenous administration of the drug. Our results indicate that Mrp1 helps to limit tissue distribution of certain drugs and contributes to the blood-CSF drug-permeability barrier.
Jan Wijnholds, Elizabeth C.M. de Lange, George L. Scheffer, Dirk-Jan van den Berg, Carla A.A.M. Mol, Martin van der Valk, Alfred H. Schinkel, Rik J. Scheper, Douwe D. Breimer, Piet Borst
Title and authors | Publication | Year |
---|---|---|
Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review
May CJ, Ford NP, Welsh GI, Saleem MA |
PLOS ONE | 2025 |
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Baltira C, Aronica E, Elmquist WF, Langer O, Löscher W, Sarkaria JN, Wesseling P, de Gooijer MC, van Tellingen O |
Cell reports. Medicine | 2024 |
Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat.
Zhang W, Liu QY, Haqqani AS, Liu Z, Sodja C, Leclerc S, Baumann E, Delaney CE, Brunette E, Stanimirovic DB |
Pharmaceutics | 2023 |
Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs.
Torres-Vergara P, Rivera R, Escudero C, Penny J |
Advances in experimental medicine and biology | 2023 |
Molecular Mechanisms of Organic Anion Transporting Polypeptide-Mediated Organic Anion Clearance at the Blood-Cerebrospinal Fluid Barrier.
Sun A, Hagenbuch B, Kelly EJ, Wang J |
Molecular pharmacology | 2023 |
Progress in characterizing ABC multidrug transporters in zebrafish
Thomas JR, Frye WJ, Robey RW, Gottesman MM |
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2023 |
Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier
Sun A, Wang J |
Pharmaceutical research | 2023 |
Evaluation of Blood-CSF Barrier Transport by Quantitative Real Time Fluorescence Microscopy.
Sun A, Wang J |
Pharmaceutical Research | 2022 |
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy.
Jang A, Petrova B, Cheong TC, Zawadzki ME, Jones JK, Culhane AJ, Shipley FB, Chiarle R, Wong ET, Kanarek N, Lehtinen MK |
Neuron | 2022 |
Live Tissue Imaging Reveals Distinct Transcellular Pathways for Organic Cations and Anions at the Blood-Cerebrospinal Fluid Barrier.
Hu T, Zha W, Sun A, Wang J |
Molecular pharmacology | 2022 |
Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
K Liu, J Song, Y Yan, K Zou, Y Che, B Wang, Z Li, W Yu, W Guo, L Zou, W Deng, X Sun |
Translational oncology | 2021 |
Choroid Plexus and Drug Removal Mechanisms
A Sun, J Wang |
The AAPS Journal | 2021 |
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease
T Behl, I Kaur, A Sehgal, A Kumar, S Uddin, S Bungau |
Molecular Neurobiology | 2020 |
Choroid plexus and the blood–cerebrospinal fluid barrier in disease
P Solár, A Zamani, L Kubíčková, P Dubový, M Joukal |
Fluids and barriers of the CNS | 2020 |
Localization of ZIP14 and ZIP8 in HIBCPP Cells
SE Morgan, H Schroten, H Ishikawa, N Zhao |
Brain Sciences | 2020 |
Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells
C Goldeman, B Ozgür, B Brodin |
Fluids and barriers of the CNS | 2020 |
Central Nervous System Metastases: Diagnosis and Treatment
R Ramakrishna, RS Magge, AA Baaj, JP Knisely |
2020 | |
A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery
L Huang, MC Wells, Z Zhao |
Drug metabolism letters | 2020 |
Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique
S Marie, N Tournier |
Thérapie | 2020 |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
Drug Transporters in Drug Disposition, Effects and Toxicity
X Liu, G Pan |
2019 | |
ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas
D Gomez-Zepeda, M Taghi, JM Scherrmann, X Decleves, MC Menet |
Pharmaceutics | 2019 |
Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters
M Grube, P Hagen, G Jedlitschky |
Frontiers in pharmacology | 2018 |
High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier
C Taccola, S Cartot-Cotton, D Valente, P Barneoud, C Aubert, V Boutet, F Gallen, M Lochus, S Nicolic, A Dodacki, M Smirnova, S Cisternino, X Declèves, F Bourasset |
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2018 |
Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche
YC Chee, J Pahnke, R Bunte, VA Adsool, B Madan, DM Virshup |
Developmental Cell | 2018 |
Development of Novel Intramolecular FRET-Based ABC Transporter Biosensors to Identify New Substrates and Modulators
B Osa-Andrews, K Tan, A Sampson, S Iram |
Pharmaceutics | 2018 |
Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species
N Srinivas, EP Rosen, WM Gilliland, M Kovarova, L Remling-Mulder, GD Cruz, N White, L Adamson, AP Schauer, C Sykes, P Luciw, JV Garcia, R Akkina, AD Kashuba |
Xenobiotica | 2018 |
Pediatric Hydrocephalus
G Cinalli, MM Ozek, C Sainte-Rose |
2018 | |
SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers
ME Morris, V Rodriguez-Cruz, MA Felmlee |
The AAPS Journal | 2017 |
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy
W Zhou, C Chen, Y Shi, Q Wu, RC Gimple, X Fang, Z Huang, K Zhai, SQ Ke, YF Ping, H Feng, JN Rich, JS Yu, S Bao, XW Bian |
Cell Stem Cell | 2017 |
Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations
Y Yamamoto, M Danhof, EC de Lange |
The AAPS Journal | 2017 |
Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies
RP Dash, RJ Babu, NR Srinivas |
European Journal of Drug Metabolism and Pharmacokinetics | 2017 |
The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an in Vitro Study
M Fic, A Gomulkiewicz, J Grzegrzolka, M Podhorska-Okolow, M Zabel, P Dziegiel, K Jablonska |
International journal of molecular sciences | 2017 |
Translating Molecules into Medicines
SN Bhattachar, JS Morrison, DR Mudra, DM Bender |
Translating Molecules into Medicines | 2017 |
Intestinal absorption mechanisms of 2′-deoxy-2′-β-fluoro-4′-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein
Y Liu, B Liu, Y Zhang, Y Peng, C Huang, N Wang, J Jiang, Q Wang, J Chang |
European Journal of Pharmaceutical Sciences | 2017 |
Inner Blood–Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig
Z Zhang, Y Uchida, S Hirano, D Ando, Y Kubo, S Auriola, S Akanuma, K Hosoya, A Urtti, T Terasaki, M Tachikawa |
Molecular Pharmaceutics | 2017 |
The effect of aging on brain barriers and the consequences for Alzheimer’s disease development
N Gorlé, CV Cauwenberghe, C Libert, RE Vandenbroucke |
Mammalian Genome | 2016 |
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
FA Javid, RM Phillips, S Afshinjavid, R Verde, A Ligresti |
European Journal of Pharmacology | 2016 |
Molecular mechanisms for tumour resistance to chemotherapy
ST Pan, ZL Li, ZX He, JX Qiu, SF Zhou |
Clinical and Experimental Pharmacology and Physiology | 2016 |
Drug Delivery: Principles and Applications
ME Morris, X Guan |
Drug Delivery: Principles and Applications | 2016 |
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
JI Fletcher, RT Williams, MJ Henderson, MD Norris, M Haber |
Drug Resistance Updates | 2016 |
Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia
L Bočkor, G Bortolussi, S Vodret, A Iaconcig, J Jašprová, J Zelenka, L Vitek, C Tiribelli, AF Muro |
Human Molecular Genetics | 2016 |
Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood–cerebrospinal fluid barrier in human brain
K Matsumoto, Y Chiba, R Fujihara, H Kubo, H Sakamoto, M Ueno |
Histochemistry and Cell Biology | 2015 |
Efflux transporters in blood-brain interfaces of the developing brain
N Strazielle, JF Ghersi-Egea |
Frontiers in neuroscience | 2015 |
Drug Transporters in the Central Nervous System
B Stieger, B Gao |
Clinical Pharmacokinetics | 2015 |
Chronic toxicological effects of β-diketone antibiotics on Zebrafish ( D anio rerio ) using transcriptome profiling of deep sequencing: TRANSCRIPTOME PROFILING OF DEEP SEQUENCING
H Wang, X Yin, F Li, RA Dahlgren, Y Zhang, H Zhang, X Wang |
Environmental Toxicology | 2015 |
Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines
AM Dalzell, P Mistry, J Wright, FM Williams, CD Brown |
Toxicology Letters | 2015 |
Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood–CSF barrier during development in the nonhuman primate (P. hamadryas)
CJ Ek, B D’Angelo, C Lehner, P Nathanielsz, C Li, C Mallard |
Reproductive Toxicology | 2015 |
Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs
EC de Lange |
Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs | 2015 |
Role of drug transporters: an overview based on knockout animal model studies
N Shin, JH Oh, YJ Lee |
Journal of Pharmaceutical Investigation | 2015 |
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O Tellingen, B Yetkin-Arik, MC Gooijer, P Wesseling, T Wurdinger, HE Vries |
Drug Resistance Updates | 2015 |
The Blood-Brain Barrier in Health and Disease, Volume One: Morphology, Biology and Immune Function
W Zhang, M Bamji-Mirza, N Chang, A Haqqani, D Stanimirovic |
The Blood-Brain Barrier in Health and Disease, Volume One: Morphology, Biology and Immune Function | 2015 |
Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood–CSF barrier during development in the nonhuman primate (P. hamadryas)
CJ Ek, B DAngelo, C Lehner, P Nathanielsz, C Li, C Mallard |
Reproductive Toxicology | 2015 |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Multidrug Resistance Protein 1 (MRP1, ABCC1), a "Multitasking" ATP-binding Cassette (ABC) Transporter
SP Cole |
The Journal of biological chemistry | 2014 |
Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats
L Huang, X Li, J Roberts, B Janosky, MH Lin |
Xenobiotica | 2014 |
Functional and genetic analysis of choroid plexus development in zebrafish
HE Henson, C Parupalli, B Ju, MR Taylor |
Frontiers in neuroscience | 2014 |
In vitro , in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1: Ibrutinib reverses MRP1-mediated multidrug resistance
H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, YJ Wang, N Anreddy, LW Fu, ZS Chen |
British Journal of Pharmacology | 2014 |
RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells
F Zhang, B Yang, S Shi, X Jiang |
Acta Histochemica | 2014 |
Neuropharmacokinetics of two investigational compounds in rats: Divergent temporal profiles in the brain and cerebrospinal fluid
C Tang, T Chen, S Kapadnis, H Hodgdon, Y Tao, X Chen, M Wen, D Costa, D Murphy, S Nolan, DG Flood, DF Welty, G Koenig |
Biochemical Pharmacology | 2014 |
Resistance to Targeted ABC Transporters in Cancer
T Efferth |
2014 | |
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi YH, Yu AM |
Current pharmaceutical design | 2014 |
The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects
EC de Lange |
Fluids and barriers of the CNS | 2013 |
The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid
J Westerhout, J Smeets, M Danhof, EC Lange |
Journal of Pharmacokinetics and Pharmacodynamics | 2013 |
Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection
I Kratzer, SA Liddelow, NR Saunders, KM Dziegielewska, N Strazielle, JF Ghersi-Egea |
Fluids and barriers of the CNS | 2013 |
ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development
Young Hee Choi, Ai-Ming Yu |
Current pharmaceutical design | 2013 |
Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches
M Hammarlund-Udenaes, EC de Lange, RG Thorne |
2013 | |
Pharmacoresistance in Epilepsy
L Rocha, EA Cavalheiro |
2013 | |
Chalcogenopyrylium Dyes as Differential Modulators of Organic Anion Transport by Multidrug Resistance Protein 1 (MRP1), MRP2, and MRP4
RL Myette, G Conseil, SP Ebert, B Wetzel, MR Detty, SP Cole |
Drug Metabolism and Disposition | 2013 |
Role of ABC transporters in the pathogenesis of Alzheimer's disease
AH Abuznait, A Kaddoumi |
ACS Chemical Neuroscience | 2012 |
Transport and Metabolism at Blood–Brain Interfaces and in Neural Cells: Relevance to Bilirubin-Induced Encephalopathy
S Gazzin, N Strazielle, C Tiribelli, JF Ghersi-Egea |
Frontiers in pharmacology | 2012 |
Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents
M Wink, ML Ashour, MZ El-Readi |
Frontiers in microbiology | 2012 |
Bilirubin Metabolism and Its Disorders
J Roy-Chowdhury, N Roy-Chowdhury |
Zakim and Boyer s Hepatology | 2012 |
Multidrug resistance-associated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzo[a]pyrene in human Caco-2 cells
S Hessel, A John, A Seidel, A Lampen |
Archives of Toxicology | 2012 |
Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E 2 produced in the brain
M Tachikawa, G Ozeki, T Higuchi, S Akanuma, K Tsuji, K Hosoya |
Journal of Neurochemistry | 2012 |
Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
M Yu, A Ocana, IF Tannock |
Cancer and Metastasis Reviews | 2012 |
Microdialysis in Drug Development
M Müller |
2012 | |
Cerebral amyloid-beta proteostasis is highly regulated by the membrane transport protein ABCC1 in mice
Markus Krohn, Cathleen Lange, Jacqueline Hofrichter, Katja Scheffler, Jan Stenzel, Johannes Steffen, Toni Schumacher, Thomas Brüning, Anne-Sophie Plath, Franziska Alfen, Anke Schmidt, Felix Winter, Katja Rateitschak, Andreas Wree, Jörg Gsponer, Lary Walker, Jens Pahnke |
Journal of Clinical Investigation | 2011 |
Mass Spectrometry in Drug Metabolism and Disposition
G Luo, C Lu, X Ding, D Zhang |
Mass Spectrometry in Drug Metabolism and Disposition | 2011 |
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat
S Gazzin, AL Berengeno, N Strazielle, F Fazzari, A Raseni, JD Ostrow, R Wennberg, JF Ghersi-Egea, C Tiribelli |
PloS one | 2011 |
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
CP Wu, CH Hsieh, YS Wu |
Molecular Pharmaceutics | 2011 |
Development and characterization of transgenic mouse models for conditional gene knockout in the blood–brain and blood-CSF barriers
MH Crouthamel, EJ Kelly, RJ Ho |
Transgenic Research | 2011 |
Preclinical prediction of human brain target site concentrations: Considerations in extrapolating to the clinical setting
J Westerhout, M Danhof, EC de Lange |
Journal of Pharmaceutical Sciences | 2011 |
Glutathione in the blood and cerebrospinal fluid: A study in healthy male volunteers
M Samuelsson, L Vainikka, K Öllinger |
Neuropeptides | 2011 |
Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells
S Li, Y Lei, Y Jia, N Li, M Wink, Y Ma |
Phytomedicine | 2011 |
P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set
Z Wang, Y Chen, H Liang, A Bender, RC Glen, A Yan |
Journal of Chemical Information and Modeling | 2011 |
Choroid plexus transport: gene deletion studies
RF Keep, DE Smith |
Fluids and barriers of the CNS | 2011 |
The Flippase Delusion?
NL Pollock, PH Niesten, R Callaghan |
Transmembrane Dynamics of Lipids Devaux/Transmembrane Dynamics of Lipids | 2011 |
Drug Targeting to the Central Nervous System
G Fricker, A Mahringer, M Ott, V Reichel |
Drug Delivery in Oncology From Basic Research to Cancer Therapy | 2011 |
Current Topics in Developmental Biology
JE Qualls, PJ Murray |
Cancer and Development | 2011 |
Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application
Jiye Yin, Jianting Zhang |
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences | 2011 |
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat
S Gazzin, AL Berengeno, N Strazielle, F Fazzari, A Raseni, JD Ostrow, R Wennberg, JF Ghersi-Egea, C Tiribelli, R Linden |
PloS one | 2011 |
Blood-Brain Barrier (BBB) Pharmacoproteomics: Reconstruction of In Vivo Brain Distribution of 11 P-Glycoprotein Substrates Based on the BBB Transporter Protein Concentration, In Vitro Intrinsic Transport Activity, and Unbound Fraction in Plasma and Brain in Mice
Y Uchida, S Ohtsuki, J Kamiie, T Terasaki |
The Journal of pharmacology and experimental therapeutics | 2011 |
Expression of multidrug resistance proteins is localized principally to the Malpighian tubules in larvae of the cabbage looper moth, Trichoplusia ni
R Labbé, S Caveney, C Donly |
The Journal of experimental biology | 2011 |
The controversial role of ABC transporters in clinical oncology
FJ Sharom, A Tamaki, C Ierano, G Szakacs, RW Robey, SE Bates |
Essays in Biochemistry | 2011 |
PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.
Mairinger S, Erker T, Muller M, Langer O |
Current drug metabolism | 2011 |
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
CD Klaassen, LM Aleksunes |
Pharmacological reviews | 2010 |
Vectorial Ligand Transport Through Mammalian Choroid Plexus
R Spector, CE Johanson |
Pharmaceutical Research | 2010 |
ABC Transporters and Drug Efflux at the Blood-Brain Barrier
S Shen, W Zhang |
Reviews in the Neurosciences | 2010 |
Phenotype Prediction of Non-Synonymous Single-Nucleotide Polymorphisms in Human ATP-Binding Cassette Transporter Genes
LL Wang, YH Liu, LL Meng, CG Li, SF Zhou |
Basic & Clinical Pharmacology & Toxicology | 2010 |
Multidrug resistance-associated proteins and implications in drug development
YH Liu, YM Di, ZW Zhou, SL Mo, SF Zhou |
Clinical and Experimental Pharmacology and Physiology | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
RW Robey, PR Massey, L Amiri-Kordestani, SE Bates |
Anti-cancer agents in medicinal chemistry | 2010 |
MDR1 gene polymorphisms and response to acute risperidone treatment
M Kastelic, J Koprivšek, BK Plesničar, A Serretti, L Mandelli, I Locatelli, I Grabnar, V Dolžan |
Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2010 |
Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor α in Cultured Glial Cells: Involvement of Nuclear Factor-κB and c-Jun N-Terminal Kinase Signaling Pathways
PT Ronaldson, T Ashraf, R Bendayan |
Molecular pharmacology | 2010 |
ATP-Binding Cassette B1 Transports Seliciclib ( R -Roscovitine), a Cyclin-Dependent Kinase Inhibitor
Z Rajnai, D Méhn, E Beéry, A Okyar, M Jani, GK Tóth, F Fülöp, F Lévi, P Krajcsi |
Drug Metabolism and Disposition | 2010 |
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?
J Pahnke, LC Walker, K Scheffler, M Krohn |
Neuroscience and biobehavioral reviews | 2009 |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Multi-Drug Resistance in Cancer
J Zhou |
2009 | |
Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier
M Niehof, J Borlak |
BMC Molecular Biology | 2009 |
Drug interactions at the blood-brain barrier: fact or fantasy?
S Eyal, P Hsiao, JD Unadkat |
Pharmacology & Therapeutics | 2009 |
Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin
R Beedholm-Ebsen, K de Wetering, T Hardlei, E Nexo, P Borst, SK Moestrup |
Blood | 2009 |
Host cell P-glycoprotein is essential for cholesterol uptake and replication of Toxoplasma gondii
I Bottova, AB Hehl, S Stefanić, G Fabriàs, J Casas, E Schraner, J Pieters, S Sonda |
The Journal of biological chemistry | 2009 |
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
TM Sissung, CE Baum, CT Kirkland, R Gao, ER Gardner, WD Figg |
Molecular Biotechnology | 2009 |
Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2
J Cattelotte, N Tournier, N Rizzo-Padoin, AH Schinkel, JM Scherrmann, S Cisternino |
Journal of Neurochemistry | 2009 |
Pharmacology
PJ McNamara, M Leggas |
Pharmacology | 2009 |
Blood–brain interfaces and cerebral drug bioavailability
JF Ghersi-Egea, KS Mönkkönen, C Schmitt, J Honnorat, M Fèvre-Montange, N Strazielle |
Revue Neurologique | 2009 |
Drug transporters: Gatekeepers controlling access of xenobiotics to the cellular interior
LA Stanley, BC Horsburgh, J Ross, N Scheer, CR Wolf |
Drug Metabolism Reviews | 2009 |
Host Cell P-glycoprotein Is Essential for Cholesterol Uptake and Replication of Toxoplasma gondii
I Bottova, AB Hehl, S Štefanić, G Fabriàs, J Casas, E Schraner, J Pieters, S Sonda |
The Journal of biological chemistry | 2009 |
Transporters as Drug Carriers: Structure, Function, Substrates
G Ecker, P Chiba |
Transporters as Drug Carriers: Structure, Function, Substrates | 2009 |
Functions of sphingolipid metabolism in mammals — Lessons from genetic defects
F Sabourdy, B Kedjouar, SC Sorli, S Colié, D Milhas, Y Salma, T Levade |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2008 |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2008 | |
Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
S Shukla, CP Wu, SV Ambudkar |
Expert Opinion on Drug Metabolism & Toxicology | 2008 |
Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties
LZ Shi, GJ Li, S Wang, W Zheng |
Toxicology in vitro : an international journal published in association with BIBRA | 2008 |
Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease
J Pahnke, O Wolkenhauer, M Krohn, LC Walker |
Current Alzheimer research | 2008 |
Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies
CD Klaassen, H Lu |
Toxicological Sciences | 2008 |
ABC multidrug transporters: structure, function and role in chemoresistance
FJ Sharom |
Pharmacogenomics | 2008 |
Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylation
LM Roberts, DS Black, C Raman, K Woodford, M Zhou, JE Haggerty, AT Yan, SE Cwirla, KK Grindstaff |
Neuroscience | 2008 |
Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces
S Gazzin, N Strazielle, C Schmitt, M Fevre-Montange, JD Ostrow, C Tiribelli, JF Ghersi-Egea |
The Journal of Comparative Neurology | 2008 |
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)
ML Holland, JD Allen, JC Arnold |
European Journal of Pharmacology | 2008 |
Mutational analysis of ABC proteins
TW Loo, DM Clarke |
Archives of Biochemistry and Biophysics | 2008 |
Neuroscience in Medicine
PM Conn |
Neuroscience in Medicine | 2008 |
Progress in Brain Penetration Evaluation in Drug Discovery and Development
X Liu, C Chen, BJ Smith |
The Journal of pharmacology and experimental therapeutics | 2008 |
Mechanistic Differences between GSH Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) and GSH Modulation of MRP1-Mediated Transport
A Rothnie, G Conseil, AY Lau, RG Deeley, SP Cole |
Molecular pharmacology | 2008 |
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice
M der Deen, W Timens, H Timmer-Bosscha, BW van der Strate, RJ Scheper, DS Postma, EG de Vries, HA Kerstjens |
Respiratory Research | 2007 |
Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
D Halter, S Neumann, SM van Dijk, J Wolthoorn, AM de Mazière, OV Vieira, P Mattjus, J Klumperman, G Meer, H Sprong |
The Journal of Cell Biology | 2007 |
A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1
X Chang |
Cancer and Metastasis Reviews | 2007 |
Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS
S May, S Letendre, R Haubrich, JA McCutchan, R Heaton, E Capparelli, R Ellis |
Journal of Neuroimmune Pharmacology | 2007 |
Central nervous system distribution kinetics of indinavir in rats
M Hamidi |
Journal of Pharmacy and Pharmacology | 2007 |
Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice
GD Kruh, MG Belinsky, JM Gallo, K Lee |
Cancer and Metastasis Reviews | 2007 |
The role of membrane transporters in drug delivery to brain tumors
AT Nies |
Cancer Letters | 2007 |
Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin
AS Falcão, C Bellarosa, A Fernandes, MA Brito, RF Silva, C Tiribelli, D Brites |
Neuroscience | 2007 |
Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid
SL Letendre, GB van den, A Hermes, SW Paul, J Durelle, JM Beck, JA McCutchan, C Okamoto, RJ Ellis |
Clinical Infectious Diseases | 2007 |
Comprehensive Medicinal Chemistry II
E Littler, XX Zhou |
Comprehensive Medicinal Chemistry II | 2007 |
Handbook of Neurochemistry and Molecular Neurobiology
VH Routh, JJ McArdle, NM Sanders, Z Song, R Wang |
Handbook of Neurochemistry and Molecular Neurobiology | 2007 |
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
É Bakos, L Homolya |
Pflügers Archiv - European Journal of Physiology | 2006 |
Human pharmacogenomic variations and their implications for antifungal efficacy
J Meletiadis, S Chanock, TJ Walsh |
Clinical microbiology reviews | 2006 |
Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents
L Cerveny, P Pavek, J Malakova, F Staud, Z Fendrich |
Epilepsia | 2006 |
Molecular cloning of several rat ABC transporters including a new ABC transporter, Abcb8, and their expression in rat testis
N Melaine, AP Satie, J Lassurguere, S Desmots, B Jegou, M Samson |
International Journal of Andrology | 2006 |
The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes
T Minich, J Riemer, JB Schulz, P Wielinga, J Wijnholds, R Dringen |
Journal of Neurochemistry | 2006 |
P-glycoprotein in the placenta: Expression, localization, regulation and function
M Ceckova-Novotna, P Pavek, F Staud |
Reproductive Toxicology | 2006 |
Blood–brain barrier and chemotherapeutic treatment of brain tumors
NA de Vries, JH Beijnen, W Boogerd, O Tellingen |
Expert Review of Neurotherapeutics | 2006 |
Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
P Breedveld, JH Beijnen, JH Schellens |
Trends in Pharmacological Sciences | 2006 |
Transport of glutathione and glutathione conjugates by MRP1
SP Cole, RG Deeley |
Trends in Pharmacological Sciences | 2006 |
Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition
T Sugiura, Y Kato, A Tsuji |
Journal of Controlled Release | 2006 |
Flavonoid–drug interactions: Effects of flavonoids on ABC transporters
ME Morris, S Zhang |
Life Sciences | 2006 |
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
A Lespine, J Dupuy, S Orlowski, T Nagy, H Glavinas, P Krajcsi, M Alvinerie |
Chemico-Biological Interactions | 2006 |
Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier
A Soontornmalai, ML Vlaming, JM Fritschy |
Neuroscience | 2006 |
Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity
S Calligaris, D Cekic, L Roca-Burgos, F Gerin, G Mazzone, JD Ostrow, C Tiribelli |
FEBS Letters | 2006 |
Brain protection at the blood-cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism
JF Ghersi-Egea, N Strazielle, A Murat, A Jouvet, A Buénerd, MF Belin |
Journal of Cerebral Blood Flow & Metabolism | 2006 |
G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 ( MDR1 ) Expression
P Song, JK Lamba, L Zhang, E Schuetz, N Shukla, B Meibohm, CR Yates |
The Journal of Clinical Pharmacology | 2006 |
Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters
S Choudhuri, CD Klaassen |
International Journal of Toxicology | 2006 |
Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1)
A Rothnie, R Callaghan, RG Deeley, SP Cole |
The Journal of biological chemistry | 2006 |
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins
RG Deeley, C Westlake, SP Cole |
Physiological reviews | 2006 |
The Cell Cycle in the Central Nervous System
D Janigro |
2006 | |
Optimizing the “Drug-Like” Properties of Leads in Drug Discovery
RT Borchardt, EH Kerns, MJ Hageman, DR Thakker, JL Stevens |
2006 | |
Choroid plexus epithelial monolayers – a cell culture model from porcine brain
C Baehr, V Reichel, G Fricker |
Cerebrospinal fluid research | 2006 |
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
S Dallas, DS Miller, R Bendayan |
Pharmacological reviews | 2006 |
ABC drug transporter at the blood–brain barrier: Effects on drug metabolism and drug response
M Ebinger, M Uhr |
European Archives of Psychiatry and Clinical Neuroscience | 2006 |
Mitochondria are sensors for HIV drugs
F Petit, B Fromenty, A Owen, J Estaquier |
Trends in Pharmacological Sciences | 2005 |
Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport
K Ito, H Suzuki, T Horie, Y Sugiyama |
Pharmaceutical Research | 2005 |
Function of prokaryotic and eukaryotic ABC proteins in lipid transport
A Pohl, PF Devaux, A Herrmann |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2005 |
ATP-binding cassette (ABC) transporters in normal and pathological lung
M der Deen, EG de Vries, W Timens, RJ Scheper, H Timmer-Bosscha, DS Postma |
Respiratory Research | 2005 |
Use ofin vitrotransporter assays to understand hepatic and renal disposition of new drug candidates
J Sahi |
Expert Opinion on Drug Metabolism & Toxicology | 2005 |
Immuno-histochemical detection of MRPs in human lung cells in culture
AR Torky, E Stehfest, K Viehweger, C Taege, H Foth |
Toxicology | 2005 |
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
W Löscher, H Potschka |
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics | 2005 |
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
EM Leslie, RG Deeley, SP Cole |
Toxicology and Applied Pharmacology | 2005 |
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
W Löscher, H Potschka |
Progress in Neurobiology | 2005 |
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
ER Lepper, K Nooter, J Verweij, MR Acharya, WD Figg, A Sparreboom |
Pharmacogenomics | 2005 |
Efflux transport systems at the blood–brain barrier and blood CSF barrier
H Kusuhara, Y Sugiyama |
International Congress Series | 2005 |
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease
H Wolburg, A Warth |
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease | 2005 |
Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application
IE Kuppens, P Breedveld, JH Beijnen, JH Schellens |
Cancer Investigation | 2005 |
The Blood-Cerebrospinal Fluid Barrier
G Silverberg, J Szmydynger-Chodobska, A Chodobski |
The Blood-Cerebrospinal Fluid Barrier | 2005 |
Modulation of p-Glycoprotein Transport Function at the Blood-Brain Barrier
B Bauer, AM Hartz, G Fricker, DS Miller |
Experimental biology and medicine (Maywood, N.J.) | 2005 |
LC/MS/MS in drug development: targeting the brain
P Song, B Meibohm, CR Yates |
BioTechniques | 2005 |
Multiple Components of 2,4-Dichlorophenoxyacetic Acid Uptake by Rat Choroid Plexus
S Lowes, D Sykes, CM Breen, LJ Ragone, DS Miller |
The Journal of pharmacology and experimental therapeutics | 2005 |
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx
RJ Veldman, S Zerp, WJ van Blitterswijk, M Verheij |
British Journal of Cancer | 2004 |
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy
P Borst, J Balzarini, N Ono, G Reid, H Vries, P Wielinga, J Wijnholds, N Zelcer |
Antiviral Research | 2004 |
The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin
I Rigato, L Pascolo, C Fernetti, JD Ostrow, C Tiribelli |
Biochemical Journal | 2004 |
Mrp4 confers resistance to topotecan and protects the brain from chemotherapy
M Leggas, M Adachi, GL Scheffer, D Sun, P Wielinga, G Du, KE Mercer, Y Zhuang, JC Panetta, B Johnston, RJ Scheper, CF Stewart, JD Schuetz |
Molecular and cellular biology | 2004 |
Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
F Gennuso, C Fernetti, C Tirolo, N Testa, F L'Episcopo, S Caniglia, MC Morale, JD Ostrow, L Pascolo, C Tiribelli, B Marchetti |
Proceedings of the National Academy of Sciences | 2004 |
Molecular basis of bilirubin-induced neurotoxicity
JD Ostrow, L Pascolo, D Brites, C Tiribelli |
Trends in Molecular Medicine | 2004 |
Rapid Production of Chicken Egg Yolk Antibodies Against Multidrug Resistance-Associated Protein 1 (MRP-1)
T Özben, I Akan |
Critical Reviews in Analytical Chemistry | 2004 |
Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes
C Mercier, C Masseguin, F Roux, J Gabrion, JM Scherrmann |
Brain Research | 2004 |
Progress in defining multidrug resistance in leukemia
J Kappelmayer, Á Simon, F Kiss, Z Hevessy |
Expert Review of Molecular Diagnostics | 2004 |
Blood-Spinal Cord and Brain Barriers in Health and Disease
E Anderson, L Ryan, H Xiong, S Swindells, J Zheng, HE Gendelman |
Blood-Spinal Cord and Brain Barriers in Health and Disease | 2004 |
The involvement of the blood–brain and the blood–cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain
D Kurrimbux, Z Gaffen, CL Farrell, D Martin, SA Thomas |
Neuroscience | 2004 |
Handbook of Analytical Separations
G Hempel |
Handbook of Analytical Separations | 2004 |
Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain
AT Nies, G Jedlitschky, J König, C Herold-Mende, HH Steiner, HP Schmitt, D Keppler |
Neuroscience | 2004 |
Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells
A Somogyvari-Vigh, AJ Kastin, J Liao, JE Zadina, W Pan |
Experimental Brain Research | 2004 |
A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence
M Sawicka, M Kalinowska, J Skierski, W Lewandowski |
Journal of Pharmacy and Pharmacology | 2004 |
Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions
K Koike, G Conseil, EM Leslie, RG Deeley, SP Cole |
The Journal of biological chemistry | 2004 |
Natural Phosphatidylcholine Is Actively Translocated across the Plasma Membrane to the Surface of Mammalian Cells
N Kälin, J Fernandes, S Hrafnsdóttir, G Meer |
The Journal of biological chemistry | 2004 |
P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline
MT Grauer, M Uhr |
Journal of Psychopharmacology (Oxford, England) | 2004 |
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx
RJ Veldman, S Zerp, WJ van Blitterswijk, M Verheij |
British Journal of Cancer | 2004 |
Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 ( Slc22a8 )-null mice
D Sykes, DH Sweet, S Lowes, SK Nigam, JB Pritchard, DS Miller |
American journal of physiology. Renal physiology | 2004 |
Fluorescein-methotrexate transport in rat choroid plexus analyzed using confocal microscopy
CM Breen, DB Sykes, C Baehr, G Fricker, DS Miller |
American journal of physiology. Renal physiology | 2004 |
Transport of HIV Protease Inhibitors Through the Blood-Brain Barrier and Interactions With the Efflux Proteins, P-Glycoprotein and Multidrug Resistance Proteins:
F Gimenez, C Fernandez, A Mabondzo |
Journal of acquired immune deficiency syndromes (1999) | 2004 |
Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen
D Ganten, K Ruckpaul, A Ruiz-Torres |
2004 | |
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
WD Figg, HL McLeod |
2004 | |
Cellular Drug Delivery
DR Lu, S Øie |
2004 | |
Differential Involvement of Multidrug Resistance-Associated Protein 1 and P-Glycoprotein in Tissue Distribution and Excretion of Grepafloxacin in Mice
H Sasabe, Y Kato, T Suzuki, M Itose, G Miyamoto, Y Sugiyama |
The Journal of pharmacology and experimental therapeutics | 2004 |
New concepts in bilirubin encephalopathy
JD Ostrow, L Pascolo, SM Shapiro, C Tiribelli |
European Journal of Clinical Investigation | 2003 |
In vitro and in vivo models for assessing drug efflux transporter activity
Y Zhang, C Bachmeier, DW Miller |
Advanced Drug Delivery Reviews | 2003 |
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel, JW Jonker |
Advanced Drug Delivery Reviews | 2003 |
P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo
O Tellingen, T Buckle, JW Jonker, MA van der Valk, JH Beijnen |
British Journal of Cancer | 2003 |
Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria
TM Davis, TQ Binh, KF Ilett, KT Batty, HL Phuöng, GM Chiswell, VD Phuong, C Agus |
Antimicrobial agents and chemotherapy | 2003 |
Bilirubin, a curse and a boon
JD Ostrow, C Tiribelli |
Gut | 2003 |
Drug efflux transporters in the CNS
H Sun, H Dai, N Shaik, WF Elmquist |
Advanced Drug Delivery Reviews | 2003 |
Do multidrug resistance-associated protein-1 and -2 play any role in the elimination of estradiol-17?-glucuronide and 2,4-dinitrophenyl-S-glutathione across the blood-cerebrospinal fluid barrier?
YJ Lee, H Kusuhara, Y Sugiyama |
Journal of Pharmaceutical Sciences | 2003 |
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
A Sparreboom, R Danesi, Y Ando, J Chan, WD Figg |
Drug Resistance Updates | 2003 |
Basal Membrane Localization of MRP1 in Human Placental Trophoblast
M Nagashige, F Ushigome, N Koyabu, K Hirata, M Kawabuchi, T Hirakawa, S Satoh, K Tsukimori, H Nakano, T Uchiumi, M Kuwano, H Ohtani, Y Sawada |
Placenta | 2003 |
Blood-brain barrier efflux transport
PL Golden, GM Pollack |
Journal of Pharmaceutical Sciences | 2003 |
The role of multidrug transporters in drug availability, metabolism and toxicity
A Bodó, É Bakos, F Szeri, A Váradi, B Sarkadi |
Toxicology Letters | 2003 |
abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice
M Uhr, MT Grauer |
Journal of Psychiatric Research | 2003 |
P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes
C Mercier, X Declèves, C Masseguin, P Fragner, M Tardy, F Roux, J Gabrion, JM Scherrmann |
Journal of Neurochemistry | 2003 |
ABC Proteins
PA Rea, R Sánchez-Fernández, S Chen, M Peng, M Klein, M Geisler, E Martinoia |
ABC Proteins | 2003 |
Drugs and the Pharmaceutical Sciences
D Thompson |
Drugs and the Pharmaceutical Sciences | 2003 |
Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis
MF de Rosa, D Sillence, C Ackerley, C Lingwood |
The Journal of biological chemistry | 2003 |
The MRP family of drug efflux pumps
GD Kruh, MG Belinsky |
Oncogene | 2003 |
Peptide Transport and Delivery into the Central Nervous System
L Prokai, K Prokai-Tatrai |
2003 | |
Impact of Drug Transporter Studies on Drug Discovery and Development
N Mizuno, T Niwa, Y Yotsumoto, Y Sugiyama |
Pharmacological reviews | 2003 |
Functional Expression of the Multidrug Resistance Protein 1 in Microglia
S Dallas, X Zhu, S Baruchel, L Schlichter, R Bendayan |
The Journal of pharmacology and experimental therapeutics | 2003 |
CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
S Choudhuri, NJ Cherrington, N Li, CD Klaassen |
Drug Metabolism and Disposition | 2003 |
Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier
Daisuke Sugiyama, Hiroyuki Kusuhara, Yong-Joo Lee, Yuichi Sugiyama |
Pharmaceutical Research | 2003 |
Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells
Salvatore Cisternino, Christophe Rousselle, Aurelio Lorico, Germana Rappa, Jean-Michel Scherrmann |
Pharmaceutical Research | 2003 |
MAMMALIANABC TRANSPORTERS INHEALTH ANDDISEASE
P Borst, RO Elferink |
Annual Review of Biochemistry | 2002 |
The Role of Drug Efflux Pumps in Acute Myeloid Leukemia
DM van der Kolk, EG de Vries, M Müller, E Vellenga |
Leukemia & Lymphoma | 2002 |
An oncological view on the blood–testis barrier
J Bart, HJ Groen, WT van der Graaf, H Hollema, NH Hendrikse, W Vaalburg, DT Sleijfer, EG de Vries |
The Lancet Oncology | 2002 |
A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance
S Conrad, HM Kauffmann, K Ito, EM Leslie, RG Deeley, D Schrenk, SP Cole |
Pharmacogenetics | 2002 |
Encyclopedia of Cancer
G Sgouros |
Encyclopedia of Cancer | 2002 |
The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1)
DP Olson, DT Scadden, RT D'Aquila, MP de Pasquale |
AIDS | 2002 |
Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs
N MIZUNO, Y SUGIYAMA |
Drug Metabolism and Pharmacokinetics | 2002 |
Role of the Multidrug Resistance Protein 1 in Protection from Heavy Metal Oxyanions: Investigations in Vitro and in MRP1-Deficient Mice
A Lorico, A Bertola, C Baum, O Fodstad, G Rappa |
Biochemical and Biophysical Research Communications | 2002 |
Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?
MA Rogawski |
Epilepsy & Behavior | 2002 |
Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney
H Kusuhara, Y Sugiyama |
Journal of Controlled Release | 2002 |
Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice
A Lorico, J Nesland, E Emilsen, O Fodstad, G Rappa |
Toxicology | 2002 |
M AMMALIAN ABC T RANSPORTERS IN H EALTH AND D ISEASE
P Borst, RO Elferink |
Annual Review of Biochemistry | 2002 |
Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1
T Hegedűs, L Őrfi, A Seprődi, A Váradi, B Sarkadi, G Kéri |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2002 |
Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs
Maarten T Huisman, Johan W Smit, Kristel M L Crommentuyn, Noam Zelcer, Hugh R Wiltshire, Jos H Beijnen, Alfred H Schinkel |
AIDS | 2002 |
Multiple Membrane-associated Tryptophan Residues Contribute to the Transport Activity and Substrate Specificity of the Human Multidrug Resistance Protein, MRP1
K Koike, CJ Oleschuk, A Haimeur, SL Olsen, RG Deeley, SP Cole |
The Journal of biological chemistry | 2002 |
Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy
SM Sisodiya, WR Lin, BN Harding, MV Squier, M Thom |
Brain | 2002 |
Confocal imaging of organic anion transport in intact rat choroid plexus
CM Breen, DB Sykes, G Fricker, DS Miller |
American journal of physiology. Renal physiology | 2002 |
Localisation of breast cancer resistance protein in microvessel endothelium of human brain:
HC Cooray, CG Blackmore, L Maskell, MA Barrand |
NeuroReport | 2002 |
Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting: Implications of the Barriers Between Blood and Brain
EC de Lange, M Danhof |
Clinical Pharmacokinetics | 2002 |
Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview
CM Kruijtzer, JH Beijnen, JH Schellens |
The oncologist | 2002 |
Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
R Yan, EM Taylor |
Drug Metabolism and Disposition | 2002 |
Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
W Löscher, H Potschka |
The Journal of pharmacology and experimental therapeutics | 2002 |
Inhibition of the Multidrug Resistance Protein 1 (MRP1) by Peptidomimetic Glutathione-Conjugate Analogs
D Burg, P Wielinga, N Zelcer, T Saeki, GJ Mulder, P Borst |
Molecular pharmacology | 2002 |
Expression and Functional Characterization of Rat Organic Anion Transporter 3 (rOat3) in the Choroid Plexus
Y Nagata, H Kusuhara, H Endou, Y Sugiyama |
Molecular pharmacology | 2002 |
Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis
Tessa ten Hove, Paul Drillenburg, Jan Wijnholds, Anje A Te Velde, Sander J H van Deventer |
Digestive Diseases and Sciences | 2002 |
The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders:
EM Taylor |
Clinical Pharmacokinetics | 2002 |
Anticancer drug resistance in primary human brain tumors
M Bredel |
Brain Research Reviews | 2001 |
The use of transgenic mice in pharmacokinetic and pharmacodynamic studies
WF Elmquist, DW Miller |
Journal of Pharmaceutical Sciences | 2001 |
Intestinal drug efflux: formulation and food effects
D Wagner, H Spahn-Langguth, A Hanafy, A Koggel, P Langguth |
Advanced Drug Delivery Reviews | 2001 |
Conditionally Immortalized Cell Lines as a New In Vitro Model for the Study of Barrier Functions
T TERASAKI, K HOSOYA |
Biological & Pharmaceutical Bulletin | 2001 |
Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 2)
H Kusuhara, Y Sugiyama |
Drug Discovery Today | 2001 |
Erythrocyte Membrane ATP Binding Cassette (ABC) Proteins: MRP1 and CFTR as Well as CD39 (Ecto-apyrase) Involved in RBC ATP Transport and Elevated Blood Plasma ATP of Cystic Fibrosis
EH Abraham, KM Sterling, RJ Kim, AY Salikhova, HB Huffman, MA Crockett, N Johnston, HW Parker, WE Boyle, A Hartov, E Demidenko, J Efird, J Kahn, SA Grubman, DM Jefferson, SC Robson, JH Thakar, A Lorico, G Rappa, AC Sartorelli, P Okunieff |
Blood Cells, Molecules, and Diseases | 2001 |
Transport of Fluorescein in MDCKII-MRP1 Transfected Cells and mrp1-Knockout Mice
H Sun, DR Johnson, RA Finch, AC Sartorelli, DW Miller, WF Elmquist |
Biochemical and Biophysical Research Communications | 2001 |
Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin
T Saito, ZJ Zhang, M Tokuriki, T Ohtsubo, Y Shibamori, T Yamamoto, H Saito |
Brain Research | 2001 |
Expression of multidrug resistance protein 1 (MRP1) in the rat cochlea with special reference to the blood–inner ear barrier
T Saito, ZJ Zhang, M Tokuriki, T Ohtsubo, I Noda, Y Shibamori, T Yamamoto, H Saito |
Brain Research | 2001 |
Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 1)
H Kusuhara, Y Sugiyama |
Drug Discovery Today | 2001 |
Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig
T Saito |
Neuroscience Letters | 2001 |
New concepts in bilirubin neurotoxicity and the need for studies at clinically relevant bilirubin concentrations
JD Ostrow, C Tiribelli |
Journal of Hepatology | 2001 |
Influence of Multidrug Resistance (MDR) Proteins at the Blood–Brain Barrier on the Transport and Brain Distribution of Enaminone Anticonvulsants
DS Cox, KR Scott, H Gao, S Raje, ND Eddington |
Journal of Pharmaceutical Sciences | 2001 |
Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
N Zelcer, T Saeki, G Reid, JH Beijnen, P Borst |
The Journal of biological chemistry | 2001 |
Transport of the β- O -Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1): REQUIREMENT FOR GLUTATHIONE OR A NON-SULFUR-CONTAINING ANALOG
EM Leslie, K Ito, P Upadhyaya, SS Hecht, RG Deeley, SP Cole |
The Journal of biological chemistry | 2001 |
Blood—Brain Barrier
D Kobiler, S Lustig, S Shapira |
2001 | |
Biological Reactive Intermediates VI
PM Dansette, R Snyder, M Delaforge, GG Gibson, H Greim, DJ Jollow, TJ Monks, IG Sipes |
2001 | |
Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models
H Sun, D W Miller, W F Elmquist |
Pharmaceutical Research | 2001 |
The blood-brain barrier and oncology: new insights into function and modulation
J Bart, HJ Groen, NH Hendrikse, WT der Graaf, W Vaalburg, EG Vries |
Cancer Treatment Reviews | 2000 |
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
J Wijnholds, CA Mol, L Deemter, M Haas, GL Scheffer, F Baas, JH Beijnen, RJ Scheper, S Hatse, ED Clercq, J Balzarini, P Borst |
Proceedings of the National Academy of Sciences | 2000 |
Drug efflux transporters and antiviral drug therapy
RB Kim |
Expert Opinion on Therapeutic Targets | 2000 |
Multidrug resistance transporters and modulation
B Tan, D Piwnica-Worms, L Ratner |
Current Opinion in Oncology | 2000 |
Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus
JF Ghersi-Egea, N Strazielle |
Microscopy Research and Technique | 2000 |
A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins
P Borst, R Evers, M Kool, J Wijnholds |
JNCI Journal of the National Cancer Institute | 2000 |
The (patho)physiological functions of the MRP family
J Renes, EG de Vries, PL Jansen, M Müller |
Drug Resistance Updates | 2000 |
Drug Delivery to the Brain
WM Pardridge |
Journal of Cerebral Blood Flow & Metabolism | 1997 |